Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury
- 5 May 2004
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 19 (7) , 1803-1807
- https://doi.org/10.1093/ndt/gfh261
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Acetylcysteine for prevention of contrast nephropathy: meta-analysisThe Lancet, 2003
- Acetylcysteine and Renal Function Following Coronary Angiographic ProceduresJAMA, 2003
- Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and InterventionJAMA, 2003
- Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)The American Journal of Cardiology, 2002
- Elevated plasma F2-isoprostanes in patients on long-term hemodialysisKidney International, 2001
- Acetylcysteine and Nephrotoxic Effects of Radiographic Contrast Agents — A New Use for an Old DrugNew England Journal of Medicine, 2000
- Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by AcetylcysteineNew England Journal of Medicine, 2000
- THE ISOPROSTANES: THEIR QUANTIFICATION AS AN INDEX OF OXIDANT STRESS STATUS IN VIVO†Drug Metabolism Reviews, 2000
- Hypercholesterolemia aggravates radiocontrast nephrotoxicity: Protective role of L-arginineKidney International, 1998
- Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or BothNew England Journal of Medicine, 1989